Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure. [electronic resource]
Producer: 20040416Description: 407-14 p. digitalISSN:- 0269-2813
- 2-Pyridinylmethylsulfinylbenzimidazoles
- Adult
- Amoxicillin -- administration & dosage
- Anti-Bacterial Agents -- administration & dosage
- Anti-Ulcer Agents -- administration & dosage
- Antigens, Bacterial -- genetics
- Bacterial Proteins -- genetics
- Benzimidazoles -- administration & dosage
- Clarithromycin -- administration & dosage
- DNA -- analysis
- Drug Evaluation
- Drug Therapy, Combination
- Dyspepsia -- drug therapy
- Female
- Helicobacter Infections -- drug therapy
- Helicobacter pylori -- genetics
- Humans
- Male
- Middle Aged
- Omeprazole -- analogs & derivatives
- Peptic Ulcer -- drug therapy
- Polymerase Chain Reaction -- methods
- Rabeprazole
- Risk Factors
- Smoking
- Tinidazole -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.